“You don’t just need to be good; you need to be better than others to drive your business,” warns Olaf Birkenmeier, Head of External Manufacturing at Polpharma Biologics, describing the evolutionary pressure facing Western biopharmaceutical manufacturers. Olaf Birkenmeier leads external
“Other CDMOs couldn’t handle these products, but we figured it out through technical grit and deep expertise,” explains Jackie Klecker, Executive Vice President of Quality and Development Services at Lifecore Biomedical. In a CDMO Live Preview episode of the PharmaSource
“Most founders dominate organisations, spending 70-hour weeks trying to control everything. But it’s not about the hours you work – it’s about the impact. That shift in mindset transformed how I built multiple successful businesses in pharma services,” explains Raman
Francisco Blanco, founder of Conducta consulting, believes the human element in CDMO-sponsor relationships has been lost in the race for efficiency. “I feel like the human component of these relationships has been lost. When I see five-star client services from
CDMO MAP Top 30 Pharma CDMO Countries in Europe 2025 Analysis of 552 CDMO manufacturing sites across Europe reveals the countries with the most facilities in operation. Created in partnership with Fuliginous Management Consulting this infographic highlights the countries which
A new event dedicated to biopharmaceutical contract manufacturing launches this May, highlighting the sector’s rapid expansion as it nears a historic $200 billion milestone. CDMO Live takes place at Rotterdam’s World Trade Center on May 7-8, 2025. It will bring
Contract development and manufacturing leaders at Advanced Therapies Week 2025 delivered a stark message: the traditional Contract Development and Manufacturing Organization (CDMO) model for cell and gene therapies must undergo radical transformation to survive. From market consolidation to artificial intelligence,
“We estimate about 8,000 metric tonnes of solvent per year are used by the industry to support solvent-based spray drying. That’s a significant impact on cost, maintenance, safety and the environment,” says Elizabeth Hickman, CEO of AustinPx, highlighting a critical
“We seek long-term partnerships where our technologies can bring genuine value-add that sustains growth. It’s not about geography – it’s about matching specialties and capabilities with companies who share our vision for innovation,” says Rocco Paracchini, Director of CDMO Business
CDMOs vs CROs vs CMOs: This infographic highlights key outsourcing services at each stage of Drug Development and expert advice
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
